Search

everythinglearnresearchcommunity

for

Search:↓

Overexpressing thrombospondin-1 in mice skin prevents UVB-induced skin damage.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

PRIDE syndrome includes skin and hair issues from cancer treatment with EGFR inhibitors.

New compounds called benzoquinolinones may treat conditions linked to excess DHT.

Topical JAK inhibitors may help children with alopecia areata regrow hair.

Four-amino acid part makes enzyme sensitive to finasteride.

Janus kinase inhibitors are promising drugs for treating autoimmune and inflammatory diseases.

The review suggests that while many AKR1C3 inhibitors show promise for treating certain cancers, more research is needed to confirm their effectiveness in humans.

Skin side effects from cancer drugs targeting EGFR can affect treatment adherence but can be managed with antibiotics like tetracycline.

Glibenclamide slows breast cancer cell growth by stopping cell division.

Natural 5AR inhibitors effectively improve mild to moderate hair loss in men.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

JAK inhibitors can effectively reverse hair loss in people with alopecia areata.

Topical JAK inhibitors may help treat some skin conditions but need more research.

Finasteride may reduce prostate cancer spread by lowering certain enzyme levels.

The topical inhibitor CUR61414 was not effective in treating basal cell carcinoma in human trials.

Applying a specific inhibitor lightens skin and hair color.

Trps1 is essential for proper hair follicle development.

Diphenylcyclopropenone treatment helps hair growth in alopecia areata by promoting blood vessel growth and cell survival.

Steroidogenesis inhibitors change but don't stop androgen production in prostate cancer.

Gefitinib can cause hair loss without scarring.

Janus kinase inhibitors show promise in treating alopecia areata but need better topical formulations.

Wedelolactone may help prevent bone damage in breast cancer by blocking certain cell signals.

Topical JAK inhibitors may help treat alopecia universalis by promoting hair regrowth.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

Tofacitinib 2% ointment helped hair regrow in 3 out of 10 patients with alopecia areata, but caused side effects like scalp irritation and raised cholesterol in some.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

5α-reductase inhibitors, like finasteride and dutasteride, effectively treat BPH, male baldness, and hirsutism, with potential for acne and prostate cancer prevention.

JAK-inhibitors are effective for treating psoriasis and show promise for other skin diseases.